Home
Infectious Disease Billing
Infectious Disease Billing Services
Infectious disease billing services for practices running consults, OPAT, antimicrobial stewardship, and infusion workflows. Physician billing services built for this specialty so coding errors stop costing you money.
The Challenge
The Financial Complexity of Infectious Disease Practices
Infectious disease practices face billing challenges that most general medical billing teams are not equipped to handle. From hospital consults and OPAT management to antimicrobial stewardship reporting and interprofessional consultations, the reimbursement environment requires specialty-specific expertise.
Consult vs. New Patient Coding Complexity
Accurately distinguishing between consult coding infectious disease services and new patient E/M services is critical. Misclassification can trigger denials, compliance exposure, or underpayment.
Our certified coders review documentation to properly capture consultative services, concurrent care and interprofessional consult codes such as CPT 99451 and CPT 99452, ensuring physicians are reimbursed for the specialty expertise they provide to hospitalists, surgeons and primary care physicians.
Key Codes We Protect
Consultative services, concurrent care, and interprofessional consult codes including CPT 99451 and CPT 99452 — ensuring full reimbursement for specialty expertise provided to hospitalists, surgeons, and PCPs.
IV Antimicrobial & Infusion Billing
IV antimicrobial billing requires precise documentation, drug coding, infusion time reporting, and payer-specific rule compliance.
Errors in infusion billing ID services often lead to under-reimbursement or denials… Especially in complex OPAT (Outpatient Parenteral Antimicrobial Therapy) programs transitioning patients from hospital to home infusion care.
Revix MD ensures proper drug administration coding, time-based infusion reporting, and coordination with infusion pharmacy documentation.
OPAT Specialization
We manage the full lifecycle of OPAT billing from hospital-based initiation through home infusion transition ensuring drug administration codes, time based reporting, and pharmacy coordination are all aligned.
Antimicrobial Stewardship Billing
Antimicrobial stewardship programs require careful documentation alignment to demonstrate clinical intervention and value.
Our infectious disease coders ensure stewardship consults, infection control oversight, and clinical guidance are documented properly for reimbursement and quality reporting compliance.
Quality + Revenue Alignment
Stewardship documentation aligned for both reimbursement and quality reporting compliance — turning clinical interventions into measurable financial outcomes.
Outpatient Infusion & Hospital Rounding
Balancing hospital consults, inpatient follow-ups, and outpatient infusion encounters requires structured charge capture and documentation alignment.
We implement reconciliation workflows across hospital interfaces, EHR systems, and practice management platforms to ensure every encounter is captured accurately.
Multi-Setting Reconciliation
Structured charge capture workflows across hospital interfaces, EHR systems, and practice management platforms — ensuring zero missed encounters across inpatient and outpatient settings.
Value-Based Care
ASP-Linked Value-Based Reimbursement (MIPS MVPs)
In 2026, antimicrobial stewardship is no longer viewed only as a clinical initiative. It is increasingly tied to value-based reimbursement under MIPS Value Pathways (MVPs).
Revix MD helps infectious disease practices align antimicrobial stewardship documentation with federal quality reporting metrics.
We don’t just bill for stewardship activities. We help capture the quality data that proves the clinical value of your ASP interventions, including reduced hospital stay metrics and infection management outcomes.
By aligning ASP documentation with 2026 value reporting frameworks, infectious disease practices can transform stewardship programs from operational cost centers into measurable revenue contributors.
Federal ComplianceInteroperable Authorization Enforcement
Federal Authorization Compliance CMS-0057-F Final Rule
The CMS-0057-F Final Rule established strict federal timelines for payer prior authorization decisions. Revix MD ensures payers adhere to these requirements while protecting access to critical infectious disease therapies. For high-cost antimicrobial therapies, payer delays can disrupt treatment continuity and delay hospital discharge.
Standard authorizations must be decided within 7 calendar days, while expedited requests must be completed within 72 hours.
For high-cost antimicrobial therapies, payer delays can disrupt treatment continuity and delay hospital discharge.
Interoperable Authorization Enforcement
For urgent infectious disease treatments such as osteomyelitis therapy or sepsis step-down management, delays in authorization for high-cost infusion medications like daptomycin can be clinically dangerous.
Revix MD uses FHIR-based interoperability workflows to accelerate authorization processing and reduce reliance on manual payer portals. This approach helps secure timely approval for outpatient antimicrobial therapies and ensures patients transition from hospital to home infusion without administrative delay.
Protecting Hospital Consult Revenue from WISER Audits
Federal oversight initiatives such as the WISeR (Wasteful and InappropriateService Reduction) Pilot Program are increasing scrutiny of hospital-based specialty consult billing. Auditors are specifically targeting infectious disease consultations that may appear improperly unbundled from hospital global services.
Federal Compliance
Revix MD performs a pre-submission forensic documentation review designed to protect infectious disease consult revenue. Our certified coders verify that documentation clearly distinguishes:
This structured compliance review neutralizes one of the leading causes of infectious disease recoupments under current audit programs.
What We Deliver
Specialized Infectious Disease Billing Expertise
Revix MD focuses exclusively on specialty-driven revenue cycle optimization. Our infectious disease billing services are structured around the realities of ID care delivery.
The G2211 complexity add-on is particularly important for infectious disease physicians managing chronic conditions such as HIV, hepatitis and recurrent infections. Our team ensures the documentation supports longitudinal care plans required to capture this additional reimbursement.
Revenue Cycle
Comprehensive Front-End & Back-End Revenue Cycle Management
“Billing” is too broad. Revenue performance depends on end-to-end revenue cycle management across every touchpoint. Revix MD combines certified coding expertise with modern agentic RCM technology , predictive analytics, and automated payer communication systems.
Front-End Revenue Protection
Revenue loss often begins before a claim is submitted. Our front-end processes include:
In 2026, referral denials increasingly occur when referring physicians are not properly updated in the federal PECOS 2.0 enrollment database. We verify referring providers before claims submission, preventing “Ineligible Provider” denials.
Back-End Revenue Optimization
Once claims are submitted, disciplined follow-through determines financial performance. Our back-end services include:
Our advanced analytics track performance metrics including Denial Velocity, First-Pass Acceptance Rate (FPAR) and Days in A/R, enabling continuous improvement across the revenue cycle.
Compliance & Credentials
Certified Coders. U.S. Compliance Standards.
Trust in medical billing and coding services begins with credentials and regulatory alignment. Our certified coders are credentialed through organizations such as AAPC and AHIMA. We prioritize audit-readiness and regulatory alignment so your infectious disease coding withstands scrutiny from both payers and federal programs.
CMS guidelines and commercial payer policies
Infectious disease documentation requirements
Modifier-25 and Modifier-57 compliance
No Surprises Act (NSA) billing protections
Interprofessional consultation coding
OPAT and antimicrobial therapy documentation
HIPAA compliance standards
Technology
Software & EHR Expertise
Technology alignment is essential for performance. Revix MD integrates seamlessly with:
Major EHR / EMR Platforms
Practice Management Systems
Clearinghouses
Hospital Interface Systems
HL7 & FHIR-Based Integration
We adapt our workflows to your existing infrastructure, ensuring:
Our approach ensures your clinical workflow and billing operations remain aligned without disruption.
Consult Revenue Maximized
A Revenue Partner for Long-Term Growth
Your physicians focus on complex infections, hospital consults, antimicrobial management and chronic infection care. Your billing partner should focus on protecting and maximizing reimbursement.
Revix MD delivers infectious disease billing services designed specifically for the U.S. healthcare environment – balancing regulatory compliance, payer strategy, and financial performance.
Why Revix MD
Why U.S. Infectious Disease Practices Choose Revix MD
Infectious disease reimbursement requires more than general billing knowledge. It requires specialty depth. Practices choose Revix MD because we offer:
Schedule Your Infectious Disease Billing Assessment
Revenue optimization in infectious disease practices requires precision and specialty insight. Partner with Revix MD to strengthen your infectious disease coding accuracy, streamline antimicrobial stewardship billing, and improve overall financial performance.
Frequently Asked Questions
What are Infectious Disease Billing Services?
Infectious Disease Billing Services specialize in coding, claims submission and revenue cycle management for U.S. infectious disease practices.
How are ID billing services different from general medical billing?
ID billing services focus on complex consult coding, antimicrobial stewardship billing and infusion billing ID requirements specific to infectious disease care.
Why is infectious disease coding more complex?
Infectious disease coding involves high-level consults, IV antimicrobial billing, hospital rounding and strict payer documentation standards.
Do you handle IV antimicrobial and outpatient infusion billing?
Yes, we manage infusion billing ID services including drug coding, time-based reporting, and payer-specific IV antimicrobial billing compliance.
How quickly can we see improvements in collections?
Most practices see measurable gains in clean claim rates, reduced A/R days, and stronger net collections within the first reporting cycle.
Last Updated
9 October 2026